/Investor DB

OurCrowd — 2025 Investments

5 investments dated 2025 · listed companies and verified rows first · show all

DiligenceSquareddiligencesquared.cominSeed · Oct 2025

DiligenceSquared provides investment-grade market research and commercial due diligence using AI voice agents to conduct parallel expert interviews at scale.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareNew York City, US

Frederik Hansen(CEO)inSoren Biltoft-Knudsen(President)inHarshil Rastogi(CTO)in

Co-investorsY CombinatorAmino CapitalFounders FactoryTwenty Two Ventures

Future Familyfuturefamily.comFeb 2025

Future Family is a San Francisco fertility-finance company offering IVF and egg-freezing payment plans, insurance and nurse coaching.

San Francisco, US

Claire Tomkins(Founder)inAlden Romney(Chief Executive Officer)

BoardLauren Kolodny(Director)inTodd Kimmel(Director)in

Co-investorsAcrew CapitalAlumni VenturesAspect VenturesBBG VenturesClear Haven Capital ManagementCorrelation Ventures+21 more

Leo AIgetleo.aiin𝕏Sep 2025

Leo AI is an engineering design co-pilot that uses a proprietary Large Mechanical Model to assist mechanical engineers in product design.

Advanced ManufacturingAI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaS

Maor Farid, PhD(Co-Founder & CEO)Moti Moravia(Co-Founder & CTO)inMaor Farid(Founder)in

Co-investorsIneffable VenturesMento vcTwo Lanterns Venture PartnersAndreessen HorowitzFlint CapitalTechAviv Founder Partners

Omnix Medicalomnixmedical.comin𝕏Oct 2025 · $25M

Omnix Medical is a biopharmaceutical company founded in 2015 that develops novel antibiotic agents to treat infections caused by drug-resistant bacteria.

BiotechHealthtechMedical Devices

Moshik Cohen-Kutnerin

Co-investorsTal VenturesXenia Venture CapitalEntrée CapitalVLX Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AngeLink

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.